やごうクリニック 消化器科 内科 内視鏡検査 泌尿器科

article

〒174-0071東京都板橋区常盤台3-24-13 ホワイトクロス5 1F

お問い合わせ03-5915-5500

辻本先生の論文・書籍等 article


Original article

  • Tsujimoto T, Kajio H. Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment. Hypertension. 2020 Aug;76(2):432-441.
  • Tsujimoto T, Kajio H. Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure. Hypertension. 2019 Dec;74(6):1541-1550.
  • Tsujimoto T, Kajio H. Use of Nitrates and Risk of Cardiovascular Events in Patients with Heart Failure with Preserved Ejection Fraction. Mayo Clin Proc. 2019 July;94(7):1210-1220.
  • Tsujimoto T, Kajio H. No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non-steroidal anti-inflammatory drugs. Diabetes Obes Metab. 2019 Aug;21(8):1978-1984.
  • Tsujimoto T, Kajio H. Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease. Sci Rep. 2019 Mar 5;9(1):3502.
  • Tsujimoto T, Kajio H. Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease. Int J Cardiol. 2019 May 1;282:1-6.
  • Tsujimoto T, Kajio H. Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease. J Am Heart Assoc. 2019 Jan 22;8(2):e011207.
  • Tsujimoto T, Kajio H. Intensive Blood Pressure Treatment for Resistant Hypertension. Hypertension. 2019 Feb;73(2):415-423.
  • Tsujimoto T, Kajio H. Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease. Int J Cardiol. 2018 Dec 15;273:1-7.
  • Tsujimoto T, Kajio H. Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control. Hypertension. 2018 Aug;72(2):323-330.
  • Tsujimoto T, Kajio H. Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction. Sci Rep. 2018 Jun 22;8(1):9556.
  • Tsujimoto T, Kajio H. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease. Eur J Prev Cardiol. 2018 Aug;25(12):1268-1277.
  • Tsujimoto T, Kajio H. Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction. Int J Cardiol. 2018 Jul 15;263:69-74.
  • Tsujimoto T, Kajio H, Shapiro MF, Sugiyama T. Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers. Mayo Clin Proc. 2018 Apr;93(4):409-418.
  • Tsujimoto T, Kajio H. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease. Int J Cardiol. 2018 Mar 15;255:111-117
  • Tsujimoto T, Kajio H. Abdominal Obesity Is Associated with an Increased Risk of All-cause Mortality in Patients with Heart Failure with Preserved Ejection Fraction. J Am Coll Cardiol 2017 Dec 5;70(22):2739-2749
  • Tsujimoto T, Kajio H, Sugiyama T. Statin Therapy in Patients with Low Serum Levels of Low-density Lipoprotein Cholesterol. Am J Cardiol. 2017 Dec 1;120(11):1947-1954.
  • Tsujimoto T, Kajio H, Sugiyama T. Favourable Changes in Mortality in People with Diabetes – U.S. NHANES 1999-2010. Diabetes Obes Metab. 2018 Jun;20(1):85-93.
  • Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers. Hypertension. 2017 Jul;70(1):103-110.
  • Tsujimoto T, Kajio H, Sugiyama T. Association between caffeine intake and all-cause and cause-specific mortality: A population-based prospective cohort study. Mayo Clin Proc. 2017;92:1190-1202.
  • Tsujimoto T, Kajio H, Sugiyama T. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. Int J Cancer. 2017 Jul 1;141(1):102-111.
  • Tsujimoto T, Sugiyama T, Kajio H. Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease. Diabetes Obes Metab. 2017 Jun;19(6):800-808.
  • Tsujimoto T. Reply to the letter: “Sweet taste disorder and vascular complications in patients with abnormal glucose tolerance”. Int J Cardiol. 2017 Feb 15;229:37.
  • Tsujimoto T, Kajio H, Sugiyama T. Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease. Mayo Clin Proc. 2016 Nov;91(11):1545-1554.
  • Tsujimoto T, Kajio H, Sugiyama T. Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012. Medicine (Baltimore). 2016 Aug;95(35):e4578.
  • Tsujimoto T, Sugiyama T, Yamamoto-Honda R, Kishimoto M, Noto H, Morooka M, Kubota K, Kamimura M, Hara H, Kajio H, Kakei M, Noda M. Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications. Medicine (Baltimore). 2016 Aug;95(33):e4307.
  • Tsujimoto T, Sugiyama T, Noda M, Kajio H. Intensive Glycemic Therapy in Patients With Type 2 Diabetes on β-Blockers. Diabetes Care. 2016 Oct;39(10):1818-26.
  • Tsujimoto T, Imai K, Kanda S, Kakei M, Kajio H, Sugiyama T. Sweet taste disorder and vascular complications in patients with abnormal glucose tolerance. Int J Cardiol. 2016 Oct 15;221:637-41.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura, A, Kakei M, Noda M. Accelerated decline of renal function in type 2 diabetes following severe hypoglycemia. J Diabetes Complications. 2016 May-Jun;30(4):681-5.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura, A, Kakei M, Noda M. Effectiveness of Prior Use of Beta-Blockers for Preventing Adverse Influences of Severe Hypoglycemia in Patients With Diabetes: An Observational Study. Medicine (Baltimore). 2015 Sep;94(39):e1629.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M. High risk of abnormal QT prolongation in the early morning in diabetic and non-diabetic patients with severe hypoglycemia. Ann Med. 2015 May;47(3):238-44.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care. 2014;37:217-25.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M. Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease. Acta Diabetol. 2015;52:307-14.
  • Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, Kimura A, Kakei M, Noda M. Seasonal Variations of Severe Hypoglycemia in Patients with Type 1 Diabetes, Type 2 Diabetes, and Non-Diabetes: Clinical Analysis of 578 Hypoglycemia Cases. Medicine (Baltimore). 2014. Nov;93(23):e148.
  • Tsujimoto T, Yamamoto-Honda R. Clinical Conditions during Severe Hypoglycemia in Patients with Diabetes. Diabetol Int. 2014;5:81–83.
  • Tsujimoto T, Kajio H, Takahashi Y, Kishimoto M, Noto H, Yamamoto-Honda R, Kamimura M, Morooka M, Kubota K, Shimbo T, Hiroe M, Noda M. Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. BMJ Open. 2011 Jan 1;1(2):e000139.
  • Tsujimoto T, Takaichi M, Endo H, Yasuda K, Kishimoto M, Noto H, Gomibuchi H, Yasuda H, Yamamoto-Honda R, Takahashi Y, Kajio H, Sasano H, Noda M. A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a Brenner tumor. Am J Med Sci. 2011 Jan;341(1):74-7.

  • Letter/comment

  • Tsujimoto T. Low diastolic blood pressure for HFpEF. Int J Cardiol. 2018 Nov 1;270:190.
  • Tsujimoto T. Effects of tastes and taste receptors. Int J Cardiol. 2018 Jun 1;260:195.
  • Tsujimoto T. Reply: Abdominal Obesity as a Risk Predictor: Closer Than Body Mass Index But Not Close Enough. J Am Coll Cardiol. 2018 Mar 27;71(12):1399.
  • Tsujimoto T. Reply to the letter: “Sweet taste disorder and vascular complications in patients with abnormal glucose tolerance”. Int J Cardiol. 2017 Feb 15;229:37.
  • Tsujimoto T, Yamamoto-Honda R. Effects of intensive glycaemic control on ischaemic heart disease. Lancet. 2015 Mar 28;385(9974):1180.
  • Tsujimoto T, Yamamoto-Honda R. Comments and Responses: Effectiveness of Combination Therapy With Statin and Another Lipid-Modifying Agent Compared With Intensified Statin Monotherapy. Ann Intern Med. 2014 Nov 4;161(9):678-9.
  • Tsujimoto T, Yamamoto-Honda R. Acarbose vs metformin for new-onset type 2 diabetes. Lancet Diabetes Endocrinol. 2014 Feb;2(2):104-5.
  • Tsujimoto T, Yamamoto-Honda R. Combination pill for cardiovascular disease. JAMA. 2014 Jan 1;311(1):92-3.

  • Coauthor

  • Nagata N, Tohya M, Takeuchi F, Suda W, Nishijima S, Ohsugi M, Ueki K, Tsujimoto T, Nakamura T, Kawai T, Miyoshi-Akiyama T, Uemura N, Hattori M. Effects of storage temperature, storage time, and Cary-Blair transport medium on the stability of the gut microbiota. Drug Discov Ther. 2019 Nov 14;13(5):256-260.
  • Nakamura T, Tsujimoto T, Yasuda K, Chujo D, Ohsugi M, Tanabe A, Ueki K, Kajio, H. Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report. Medicine (Baltimore). 2019 Jul;98(30):e16573.
  • Nagata N, Tohya M, Fukuda S, Suda W, Nishijima S, Takeuchi F, Ohsugi M, Tsujimoto T, Nakamura T, Shimomura A, Yanagisawa N, Hisada Y, Watanabe K, Imbe K, Akiyama J, Mizokami M, Miyoshi-Akiyama T, Uemura N, Hattori M. Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019 Mar 11;9(1):4042.
  • Inoue K, Leung AM, Sugiyama T, Tsujimoto T, Makita N, Nangaku M, Ritz BR. Urinary Iodine Concentration and Mortality Among U.S. Adults. Thyroid. 2018 Jul;28(7):913-920.
  • Takahashi N, Chujo D, Tsujimoto T, Kajio H. Short-term changes in pancreatic α-cell function after the onset of fulminant type 1 diabetes. J Diabetes Investig. 2018 May;9(3):636-637.
  • Inoue K, Tsujimoto T, Sugiyama T. Life Expectancy of Patients With Low-Normal Thyroid Function. JAMA Intern Med. 2018 Mar 1;178(3):437.
  • Kikuchi T, Chujo D, Takahashi K, Takahashi N, Tanno Y, Tonoike M, Ihana N, Tsujimoto T, Tanabe A, Kajio H. A Case of Insulinoma Presenting with Reactive Hypoglycemia: Evaluating the Effect of Tumor Resection via Continuous Glucose Monitoring. Intern Med. 2017 Nov 15;56(22):3067-3071.
  • Sugiyama T, Miyo K, Tsujimoto T, Kominami R, Ohtsu H, Ohsugi M, Waki K, Noguchi T, Ohe K, Kadowaki T, Kasuga M, Ueki K, Kajio H. Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS). Diabetol Int. 2017 Jun 27;8(4):375-382.
  • Takahashi N, Tsujimoto T, Chujo D, Kajio H. High risk of renal dysfunction in patients with fulminant type 1 diabetes. J Diabetes Investig. 2018 Jan;9(1):146-151.
  • Ihana-Sugiyama N, Yamamoto-Honda R, Sugiyama T, Tsujimoto T, Kakei M, Noda M. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus. Med Sci Monit Basic Res. 2017 Feb 28;23:36-44.
  • Takahashi N, Tsujimoto T, Inoue K, Kishimoto M, Kajio H. Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec. J Diabetes Investig. 2016 Sep;7(5):805-6.
  • Inoue K, Tsujimoto T, Saito J, Sugiyama T. Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States. Thyroid. 2016 Oct;26(10):1457-1465.
  • Sugiyama T, Miyo K, Tsujimoto T, Kominami R, Ohtsu H, Ohsugi M, Waki K, Noguchi T, Ohe K, Kadowaki T, Kasuga M, Ueki K, Kajio H. Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS). Diabetol Int. 2017 Jun 27;8(4):375-382.
  • Wakabayashi S, Tsujimoto T, Kishimoto M, Ikeda N, Inoue K, Ihana N, Hamasaki, H, Noto H, Yamamoto-Honda R, Kajio H, Noda M. Acute Multiple Arteriovenous, Thromboses in a Patient with Diabetic Ketoacidosis. Intern Med. 2015;54(16):2025-8.
  • Sako A, Yasunaga H, Matsui H, Fushimi K, Hamasaki H, Katsuyama H, Tsujimoto T, Goto A, Yanai H. Hospitalization for Hypoglycemia in Japanese Diabetic Patients: A Retrospective Study Using a National Inpatient Database, 2008-2012. Medicine (Baltimore). 2015 Jun;94(25):e1029.
  • Inoue K, Goto A, Kishimoto M, Tsujimoto T, Yamamoto-Honda R, Noto H, Kajio H, Terauchi Y, Noda M. Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases. Clin Exp Nephrol. 2015 Dec;19(6):1179-83.
  • Takahashi N, Tsujimoto T, Kajio H. Comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082. Diabetes Care. 2014 Oct;37(10):e224.
  • Imai K, Tsujimoto T, Goto A, Goto M, Kishimoto M, Yamamoto-Honda R, Noto H, Kajio H, Noda M. Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes. Diabetol Metab Syndr. 2014 Oct 15;6(1):110. doi: 10.1186/1758-5996-6-110. eCollection 2014.
  • Inoue K, Tsujimoto T, Yamamoto-Honda R, Goto A, Kishimoto M, Noto H, Kajio H, Doi S, Miyazaki S, Terauchi Y, Noda M. A newer conversion equation for the correlation between HbA1c and glycated albumin. Endocr J. 2014 Jun 29;61(6):553-60.
  • Ihana N, Tsujimoto T, Yamamoto-Honda R, Kishimoto M, Kajio H, Noto H, Kakei M, Noda M. Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study. Diabetol Metab Syndr. 2014 Mar 31;6:48.
  • Noto H, Goto A, Tsujimoto T, Noda M. Effect of calcium channel blockers on incidence of diabetes: a meta-analysis. Diabetes Metab Syndr Obes. 2013 Jul 26;6:257-61.
  • Noto H, Goto A, Tsujimoto T, Osame K, Noda M. Latest insights into the risk of cancer in diabetes. J Diabetes Investig. 2013 May 6;4(3):225-32.
  • Noto H, Goto A, Tsujimoto T, Noda M. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 6. Diabetes and cancer]. Nihon Naika Gakkai Zasshi. 2013 Apr 10;102(4):869-74. Review. Japanese.
  • Noto H, Goto A, Tsujimoto T, Noda M. Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies. PLoS One. 2013;8(1):e55030.
  • Imai K, Kishimoto M, Tsujimoto T, Yamamoto-Honda R, Ihana N, Ono K, Hachiya R, Inoue K, Goto M, Goto A, Noto H, Kajio H, Noda M. Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess. Intern Med. 2013;52(23):2629-33.
  • Goto M, Inoue K, Tanaka T, Kaneko Y, Goto A, Imai K, Ihana N, Tsujimoto T, Kosuga Y, Seki Y, Kasama K, Yasuda K, Kishimoto M, Takahashi Y, Kajio H, Noda M. A morbid obese Japanese woman with a body mass index of 83.2 kg/m2: before and after sleeve gastrectomy. Intern Med. 2012;51(8):969-75.
  • Noto H, Goto A, Tsujimoto T, Noda M. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One. 2012;7(3):e33411.
  • Wada T, Kubota K, Minamimoto R, Morooka M, Hasuo K, Yotsu R, Yazaki H, Oka S, Tsujimoto T, Noda M. FDG uptake by a condylomata acuminata in an HIV-infected patient mimicked urine contamination. Clin Nucl Med. 2012 Apr;37(4):420-1.
  • Noto H, Tsujimoto T, Noda M. Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians. J Diabetes Investig. 2012 Feb 20;3(1):24-33.
  • Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011 Jul-Aug;17(4):616-28.
  • Takarabe D, Rokukawa Y, Takahashi Y, Goto A, Takaichi M, Okamoto M, Tsujimoto T, Noto H, Kishimoto M, Kaburagi Y, Yasuda K, Yamamoto-Honda R, Tsukada K, Honda M, Teruya K, Kajio H, Kikuchi Y, Oka S, Noda M. Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy. J Clin Endocrinol Metab. 2010 Aug;95(8):4056-60.

  • 書籍執筆

  • エルゼビア・ジャパン『今日の臨床サポート』「高中性脂肪(トリグリセリド)血症」 辻本哲郎
  • レジデントのための『糖尿病・代謝・内分泌内科 ポケットブック』野田光彦 (監修), 田中隆久 (編集), 辻本哲郎 (編集), 小菅由果 (編集), 財部大輔(編集)
  • レジデントのための『糖尿病・代謝・内分泌内科 ポケットブック(第2版)』野田光彦 (監修), 田中隆久 (編集), 辻本哲郎 (編集), 小菅由果 (編集), 財部大輔(編集)
  • 女性と健康の百科事典第67章「静脈血栓塞栓症」. 辻本哲郎
  • 看護学テキスト NiCE病態・治療編 内分泌・代謝疾患 第4, 5, 7節. 辻本哲郎
  • プレシジョン『今日の問診票』カルシトニン、副腎偶発腫、副甲状腺ホルモン、副甲状腺ホルモン関連蛋白. 辻本哲郎
  • 総説・著述

  • 著明な高血糖の治療「DKA&HHSの専門施設の治療」. 科学評論社. 2012年. 今井健二郎、辻本哲郎、本田律子
  • 1型および2型糖尿病患者における重度低血糖時のバイタルサイン,QT延長,心血管疾患の新規診断. Diabetes Care 日本語版 Vol.2 No.3. 辻本哲郎
  • 特集 糖尿病強化療法-低血糖を巡る諸問題「重症低血糖症例における心血管リスク」Diabetes Frontier. Vol.25. No.4. 2014. 辻本哲郎、後藤温、野田光彦
  • 重症低血糖と心血管疾患. 糖尿病学. 2015年. 辻本哲郎、後藤温、野田光彦
  • 重症低血糖と死亡・心血管リスクについて. プラクティス 2015年. 辻本哲郎
  • 重症低血糖の病態について. プラクティス 2015年. 辻本哲郎
  • 重症低血糖を避けるための対策について. プラクティス 2015年. 辻本哲郎
  • スタッフが行く「多摩北部医療センター」. プラクティス 2015年. 辻本哲郎
  • 重症低血糖と心血管リスク. 最新医学 70巻2015年7月増刊号. 辻本哲郎
  • 重症低血糖を避けるコツ. medicina 53巻1号2015年. 辻本哲郎
  • 重症低血糖を避ける(経口血糖降下薬). 月間糖尿病 2016年. 辻本哲郎
  • 特集「糖尿病と高血圧」 低血糖と高血圧・不整脈. 先端医学社「血圧」2016年. 辻本哲郎
  • 糖尿病患者の降圧治療を再考する「β遮断薬の効果、ホントはどっち?」日経メディカル 2017年. 辻本哲郎
  • β遮断薬使用中の糖尿病患者における心血管イベントリスク. 月間誌『血圧』 2017年. 辻本哲郎
  • OVERSEAS「β遮断薬内服中の2型糖尿病患者における厳格な血糖管理」プラクティス 2017年. 辻本哲郎、能登洋
  • 「診療録直結型全国糖尿病データベース事業(J-DREAMS)概要と目指すもの」医薬ジャーナル 2017年7月号. 辻本哲郎、植木浩二郎
  • J-DREAMS. Diabetes Journal. Vol.45 No.2 2017. 辻本哲郎、植木浩二郎
  • 重症化させない 低血糖の対策と血糖管理のコツ 「低血糖のメカニズム」. 調剤と情報 2017年. 辻本哲郎
  • 特集 循環器疾患のprecision medicine「糖尿病におけるprecision medicine」. 科学評論社2017年. 辻本哲郎、植木浩二郎
  • 糖尿病特集「第7章 薬物療法:注射薬による治療(①インスリン製剤)」Hospitalist Vol.6 No.2 2018. 辻本哲郎
  • 糖尿病の療養指導Q&A メトホルミン処方にあたっての注意点について教えてください. プラクティス 2018年. 辻本哲郎、能登洋
  • 低血糖の臨床像. プラクティス 2018年. 辻本哲郎
  • 基礎医学講座I. 低血糖の臨床像. 機関紙「救急救命」第41号2018年. 辻本哲郎
  • 標準的な血糖管理を受けている2型糖尿病患者における厳格な血圧管理の恩恵. 月間誌『血圧』 2018年. 辻本哲郎
  • 特集 糖尿病診療の“Q”現場の疑問に答えます「薬物療法:経口血糖降下薬 どの薬から使用すればよいのだろう?」medicina Vol.56 No.6 2019. 辻本哲郎
  • 治療抵抗性高血圧における厳格な血圧管理. 月間誌『血圧』 2019年. 辻本哲郎
  • 特集 デキル内科医のコンサルト 専門医が教える隠れたエッセンス コンサルトを依頼する 糖尿病患者の血糖管理 medicina Vol.57 No.5 2020. 辻本哲郎
  • 糖尿病エキスパートブック 糖尿病患者における血圧管理 月刊「臨床栄養」第136巻 第6号(臨時増刊号). 辻本哲郎

  • ガイドライン、各種委員会委員等

  • 糖尿病診療ガイドライン2019 システマティックレビューサポートチーム
  • 糖尿病診療ガイドライン2016 システマティックレビューサポートチーム
  • 診療録直結型全国糖尿病データベース事業(J-DREAMS) 委員
  • 日医かかりつけ医糖尿病データベース研究事業(J-DOME) 委員
  • 日本神経救急学会 神経蘇生ガイドライン2015 委員会委員
  • やごうクリニック

    174-0071
    東京都板橋区常盤台3-24-13 ホワイトクロス5 1F

    • 東武東上線「ときわ台駅」徒歩8分
      東武東上線「上板橋駅」徒歩8分

    • お問い合わせ03-5915-5500

    診療時間
    -
    -
    【休診日:木曜午後、土曜午後、日曜祝日】

    … 第四木曜日、第三土曜日は終日休診です。

    … 水曜日午後の診療は15:00〜18:30です。


    受付は診療開始の30分前からとなります。
    *午後の受付は午前中には行えません。